Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy

Satsuki Yamada, D. Kent Arrell, Almudena Martinez-Fernandez, Atta Behfar, Garvan C. Kane, Carmen M. Perez-Terzic, Ruben J. Crespo-Diaz, Robert J. McDonald, Saranya P. Wyles, Jelena Zlatkovic-Lindor, Timothy J. Nelson, Andre Terzic

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Background: Cardiac resynchronization therapy using bi-ventricular pacing is proven effective in the management of heart failure (HF) with a wide QRS-complex. In the absence of QRS prolongation, however, device-based resynchronization is reported unsuitable. As an alternative, the present study tests a regenerative cell-based approach in the setting of narrow QRS-complex HF. Methods and Results: Progressive cardiac dyssynchrony was provoked in a chronic transgenic model of stress-triggered dilated cardiomyopathy. In contrast to rampant end-stage disease afflicting untreated cohorts, stem cell intervention early in disease, characterized by mechanical dyssynchrony and a narrow QRS-complex, aborted progressive dyssynchronous HF and prevented QRS widening. Stem cell-treated hearts acquired coordinated ventricular contraction and relaxation supporting systolic and diastolic performance. Rescue of contractile dynamics was underpinned by a halted left ventricular dilatation, limited hypertrophy, and reduced fibrosis. Reverse remodeling reflected a restored cardiomyopathic proteome, enforced at systems level through correction of the pathological molecular landscape and nullified adverse cardiac outcomes. Cell therapy of a dyssynchrony-prone cardiomyopathic cohort translated prospectively into improved exercise capacity and prolonged survivorship. Conclusions: In narrow QRS HF, a regenerative approach demonstrated functional and structural benefit, introducing the prospect of device-autonomous resynchronization therapy for refractory disease.

Original languageEnglish (US)
Article numbere001614
JournalJournal of the American Heart Association
Issue number5
StatePublished - May 2015
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by the National Institutes of Health (R01HL64822, T32HL07111), American Heart Association, Leducq Fondation, Marriott Heart Disease Research Program, and Mayo Clinic Center for Regenerative Medicine. Dr Terzic holds the Marriott Family Professorship in Cardiovascular Research and is the Michael S. and Mary Sue Shannon Director, Mayo Clinic Center for Regenerative Medicine.

Funding Information:
The authors thank Jonathan J. Nesbitt, Lois A. Rowe, Diane M. Jech, Courtney Rust, Nicolas L. Carlblom, Sarah Burrington, Andrea Clement, Maxwell J. Klepper, and Brock K. Johnson for assistance, as well as the Mayo Clinic Proteomics Research Center and NMR Core Facility for guidance in data acquisition. The authors are grateful to Drs Takashi Miki (Chiba University, Chiba, Japan) and Susumu Seino (Kobe University, Kobe, Japan) for initial derivation of the knockout model.

Publisher Copyright:
© 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.


  • mechanical discordance
  • proteome
  • resynchronization
  • speckle-tracking
  • stem cells


Dive into the research topics of 'Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy'. Together they form a unique fingerprint.

Cite this